HWKN
Hawkins IncPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted EBITDA non-GAAP | $34.8M | three months ended December 28, 2025 | — |
| trailing 12-month Adjusted EBITDA non-GAAP | $179M | trailing 12 months ended December 28, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HWKN
this stock
Hawkins Inc
|
$2.97B | +0.5% | +11.2% | 36.5 | 5.1% |
|
LIN
Linde PLC
|
$240.89B | +21.0% | +3.0% | 34.5 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$125.91B | +6.9% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.40B | +3.0% | +26.4% | 32.5 | 3.2% |
|
ECL
Ecolab Inc.
|
$77.60B | +3.2% | +2.2% | 37.3 | 1.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HWKN | +7.6% | -10.4% | -7.4% | +0.2% | +0.5% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +6.4% | -10.2% | -17.5% | -0.9% | -10.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.